Some FDA-recalled medical devices remain in use while manufacturers implement corrections
Editor's Note A 2016 recall issued for the Abbott MitraClip cardiac device highlighted potential safety concerns, but instead of removing the product from the market, Abbott and the Food and Drug Administration (FDA) allowed continued use with revised instructions and additional training for doctors. This approach reflects a broader trend…
FDA warns healthcare providers to conserve blood culture media bottles amid shortage
Editor's Note Healthcare providers should consider strategies to conserve BD BACTEC blood culture media bottles for patients at highest risk due to an ongoing shortage, according to a July 10 report from The US Food and Drug Administration (FDA). Attributing the shortage to supplier issues, FDA warns that the disruption…
FDA warns of continued cardiac pump safety concerns after series of recalls
Editor's Note The US Food and Drug Administration (FDA) is urging healthcare providers to avoid using Getinge heart devices due to continued safety concerns that remain unaddressed despite previous recalls. Issued to healthcare providers May 8, the warning letter applies to Getinge/Maquet/Datascope Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pump (IABP) devices…
Joint replacement manufacturer recalls products after FDA packaging warning
Editor's Note A January complaint about inefficient packaging for joint replacement products has prompted the manufacturer to recall certain knee and shoulder system devices after initially declining to take the products off the market, according to an April 23 report in Health Exec. The manufacturer, Exactech, is now recalling a…
FDA updates warning about plastic syringes made in China
Editor's Note An ongoing US Food and Drug Administration (FDA) evaluation of plastic syringes made in China reveals that quality problems are more widespread than initially believed, the agency reported on March 19. The update to an original November 23 safety notice recommends the following action to alleviate potential quality…
FDA issues warning on fraudulent, unreliable medical device testing data
Editor's Note The FDA has issued a warning regarding fraudulent, duplicated and otherwise unreliable data coming from third party test labs that produce data for medical device companies, including many based in India and China. Issued February 20, the alert warns medical device manufacturers that they are responsible for confirming the…
FDA updates safety recall of certain saline, sterile water medical products
Editor's Note The US Food and Drug Administration (FDA) on January 24 updated its safety recall communication from November 6 to add to the voluntary recalls of saline and sterile water medical products associated with Nurse Assist, LLC. The FDA recall notice lists various water-based medical products manufactured by Nurse…
FDA safety alert targets shoulder implant packaging
Editor's Note: Equinoxe Shoulder System joint replacement devices manufactured by Exactech between 2004 and 2021 are at risk of premature wearing or failure due to defective packaging, according to a January 16 safety alert from the US Food and Drug Administration (FDA). The bags used to package the devices were…
Superpotency concerns spur recall of IV bags for vancomycin, phenylephrine, and fentanyl
Editor's Note: Englewood, Colo,-based Leiters Health is voluntarily recalling 33 lots of vancomycin, phenylephrine, and fentanyl IV bags due to concerns that they may contain twice the labeled amount of drug, according to a January 8 safety alert from the US Food and Drug Administration (FDA). “The semi-automated IV bag…
FDA issues safety notice for syringes made in China
Editor's Note The US Food and Drug Administration (FDA) issued a safety notice on November 30 regarding quality concerns related to several Chinese manufacturers of syringes. The FDA is evaluating these devices for potential problems, including leaks, breakages, and the presence of particles in the syringes. According to the safety…
Free Daily News
- Task force aims to reduce discarded organs, boost transplants
- Epic to expand AI automation
- 2025 Medicare reimbursement cuts spark concern among physicians
- Trump vs. Harris: Key differences in healthcare proposals for Medicaid, Medicare, private insurance, abortion
- Updated AAMI standard addresses chemical sterilization safety, compliance
- Study: Stool tests show promise in reducing colonoscopies for post-polypectomy colorectal cancer surveillance
- Healthcare employment up in October
- Save the date for OR Manager Conference 2025
- Session: Staff resilience during extended downtime
- Session: Managing difficult conversations—How to respond effectively to your team